TELA Bio files Schedule 13G/A showing 5.5% stake

TELA Bio, Inc. ownership update: Laurence W. Lytton amended a Schedule 13G/A to report beneficial ownership of 2,442,341 shares of Common Stock, equal to 5.5% of the class.

Rhea-AI Filing Summary

TELA Bio, Inc. ownership update: Laurence W. Lytton amended a Schedule 13G/A to report beneficial ownership of 2,442,341 shares of Common Stock, equal to 5.5% of the class.

The filing states the percentage is based on 44,740,371 shares outstanding as of March 16, 2026. The amendment is signed on May 15, 2026.

Insights

Corporate Governance Specialist

Holder reports a passive 5.5% stake in TELA Bio.

Schedule 13G/A amendments typically record passive investors or holdings above reporting thresholds. The filing lists 2,442,341 shares and a 5.5% stake, using March 16, 2026 as the outstanding-share anchor.

Future disclosures or additional amendments would show any change in position; timing and intent beyond this amended report are not stated in the excerpt.

Regulatory Compliance Analyst

Amendment provides updated beneficial-ownership facts and voting/dispositive power.

The filing clearly states sole voting power and sole dispositive power of 2,442,341 shares for the reporting person. It cites the issuer's Form 10-K for the outstanding-share count used to calculate 5.5%.

Maintaining an accurate Schedule 13G/A aligns the holder with SEC reporting obligations; no change-of-control or transaction detail is disclosed here.

Key Figures

Beneficially owned: 2,442,341 shares Percent of class: 5.5% Shares outstanding: 44,740,371 shares +1 more

4 metrics

Beneficially owned 2,442,341 shares Amount beneficially owned by Laurence W. Lytton (Schedule 13G/A)

Percent of class 5.5% Percent of Common Stock based on outstanding shares as of <date>March 16, 2026</date>

Shares outstanding 44,740,371 shares Shares outstanding used for percentage calculation as of <date>March 16, 2026</date>

Signature date 05/15/2026 Date the reporting person signed the amendment

Key Terms

Schedule 13G/A, Beneficially owned, Sole dispositive power

3 terms

Schedule 13G/A regulatory

"Amendment No. 4 ) TEL A Bio, Inc. Common Stock"

A Schedule 13G/A is an amended public filing with the U.S. securities regulator that updates a previous Schedule 13G, disclosing when an individual or group holds a substantial (typically over 5%) stake in a company and is claiming a passive, non‑controlling intent. Investors monitor these updates because rising or falling holdings can signal changing confidence, potential future moves, or shifts in voting power — like watching a public ledger where large shareholders quietly adjust their positions.

Beneficially owned financial

"Item 4. | Ownership (a) | Amount beneficially owned: 2,442,341"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

Sole dispositive power regulatory

"Sole power to dispose or to direct the disposition of: 2,442,341"

Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stake does Laurence W. Lytton report in TELA (TELA)?

He reports beneficial ownership of 2,442,341 shares, representing 5.5% of Common Stock. The percentage is calculated using 44,740,371 shares outstanding as of March 16, 2026.

Does the filing state voting or disposition power for the reported shares?

Yes. The amendment states the reporting person has sole voting power and sole dispositive power over 2,442,341 shares, with no shared voting or dispositive power reported.

When was the Schedule 13G/A amendment signed and filed?

The amendment is signed by Laurence W. Lytton on May 15, 2026. The filing references the outstanding-share count as of March 16, 2026 for percentage calculations.

What outstanding-share figure does the filing use to compute the 5.5% stake?

The calculation uses 44,740,371 shares of Common Stock outstanding as of March 16, 2026, as reported in the issuer's Form 10-K for the fiscal year ended December 31, 2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/15/2026 - 01:05 PM EDT Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 4)

TELA Bio, Inc.

(Name of Issuer)

Common Stock

(Title of Class of Securities)

872381108

(CUSIP Number)

03/31/2026

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

schemaVersion:

SCHEDULE 13G

CUSIP Number(s): 872381108

1

Names of Reporting Persons

Lytton, Laurence W.

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 2,442,341.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 2,442,341.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

2,442,341.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

5.5 %

12

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person: The percentages reported in this Schedule 13G are based on 44,740,371 shares of Common Stock outstanding as of March 16, 2026, as reported in the Form 10-K filed by the Issuer for the fiscal year ended December 31, 2025.

SCHEDULE 13G

Item 1.
(a)	Name of issuer: TELA Bio, Inc.
(b)	Address of issuer's principal executive offices: 1 Great Valley Parkway, Suite 24, Malvern, PA 19355
Item 2.
(a)	Name of person filing: Laurence W. Lytton
(b)	Address or principal business office or, if none, residence: 467 Central Park West New York, NY 10025
(c)	Citizenship: United States
(d)	Title of class of securities: Common Stock
(e)	CUSIP No.: 872381108
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 2,442,341
(b)	Percent of class: 5.5%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 2,442,341
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 2,442,341
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Lytton, Laurence W.

Signature:	/s/ Laurence W. Lytton
Name/Title:	Reporting Person
Date:	05/15/2026